376 related articles for article (PubMed ID: 24656734)
1. Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.
Iyer CC; McGovern VL; Wise DO; Glass DJ; Burghes AH
Neuromuscul Disord; 2014 May; 24(5):436-44. PubMed ID: 24656734
[TBL] [Abstract][Full Text] [Related]
2. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
3. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.
Bodine SC; Baehr LM
Am J Physiol Endocrinol Metab; 2014 Sep; 307(6):E469-84. PubMed ID: 25096180
[TBL] [Abstract][Full Text] [Related]
5. [MAFbx and MuRF1 mRNA expression and its relationship with muscular contractility following free muscle transfer].
Liu AT; Yu DZ; Zhang YF; Zhang WJ; Ding WJ; Ren AJ; Fang CP; Jiang H
Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 May; 25(3):217-21. PubMed ID: 19803207
[TBL] [Abstract][Full Text] [Related]
6. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes.
Lee MK; Kim YM; Kim IH; Choi YH; Nam TJ
Mol Med Rep; 2017 Jun; 15(6):3507-3514. PubMed ID: 28393223
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Ligustrazine on expressions of FoXO3a, MAFbx, and MuRF1 in denervated skeletal muscle atrophy rats].
Wang H; Liang B; Peng C; Wang P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 May; 26(5):597-600. PubMed ID: 22702057
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.
Tang H; Inoki K; Lee M; Wright E; Khuong A; Khuong A; Sugiarto S; Garner M; Paik J; DePinho RA; Goldman D; Guan KL; Shrager JB
Sci Signal; 2014 Feb; 7(314):ra18. PubMed ID: 24570486
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation.
Gomes AV; Waddell DS; Siu R; Stein M; Dewey S; Furlow JD; Bodine SC
FASEB J; 2012 Jul; 26(7):2986-99. PubMed ID: 22508689
[TBL] [Abstract][Full Text] [Related]
10. The mERG1a channel modulates skeletal muscle MuRF1, but not MAFbx, expression.
Pond AL; Nedele C; Wang WH; Wang X; Walther C; Jaeger C; Bradley KS; Du H; Fujita N; Hockerman GH; Hannon KM
Muscle Nerve; 2014 Mar; 49(3):378-88. PubMed ID: 23761265
[TBL] [Abstract][Full Text] [Related]
11. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles.
Okamoto T; Torii S; Machida S
J Physiol Sci; 2011 Nov; 61(6):537-46. PubMed ID: 21901639
[TBL] [Abstract][Full Text] [Related]
14. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.
Watson ML; Baehr LM; Reichardt HM; Tuckermann JP; Bodine SC; Furlow JD
Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1210-20. PubMed ID: 22354783
[TBL] [Abstract][Full Text] [Related]
15. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin ligases MuRF1 and MAFbx in human skeletal muscle atrophy.
de Palma L; Marinelli M; Pavan M; Orazi A
Joint Bone Spine; 2008 Jan; 75(1):53-7. PubMed ID: 17977773
[TBL] [Abstract][Full Text] [Related]
17. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
20. Differences in the Role of HDACs 4 and 5 in the Modulation of Processes Regulating MAFbx and MuRF1 Expression during Muscle Unloading.
Mochalova EP; Belova SP; Kostrominova TY; Shenkman BS; Nemirovskaya TL
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32646070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
